We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYRX icon
2201
CryoPort
CYRX
$750M
$210K ﹤0.01%
25,348
+3,715
+17% +$33.6K
UNTY icon
2202
Unity Bancorp
UNTY
$586M
$210K ﹤0.01%
4,046
EBS icon
2203
Emergent Biosolutions
EBS
$377M
$209K ﹤0.01%
25,237
-6,182
-20% -$64K
AHRT
2204
AH Realty Trust
AHRT
$540M
$209K ﹤0.01%
37,919
-7,931
-17% -$50.6K
AKTS
2205
Aktis Oncology
AKTS
$1.28B
$208K ﹤0.01%
+11,637
New +$226K
LAND
2206
Gladstone Land Corp
LAND
$367M
$208K ﹤0.01%
20,381
+4,357
+27% +$46.9K
TECX
2207
Tectonic Therapeutic
TECX
$535M
$208K ﹤0.01%
6,724
VNDA icon
2208
Vanda Pharmaceuticals
VNDA
$299M
$208K ﹤0.01%
30,048
+5,638
+23% +$43.5K
YEXT icon
2209
Yext
YEXT
$568M
$207K ﹤0.01%
53,868
+3,236
+6% +$19.5K
CENT icon
2210
Central Garden & Pet Co
CENT
$2.74B
$207K ﹤0.01%
5,625
FFWM
2211
DELISTED
First Foundation Inc
FFWM
$206K ﹤0.01%
34,835
+6,211
+22% +$37.7K
MOV icon
2212
Movado Group
MOV
$836M
$205K ﹤0.01%
8,415
HBCP icon
2213
Home Bancorp
HBCP
$562M
$205K ﹤0.01%
3,391
+26
+0.8% +$1.56K
NPB
2214
Northpointe Bancshares
NPB
$604M
$205K ﹤0.01%
11,871
QXO
2215
QXO Inc
QXO
$14B
$205K ﹤0.01%
10,550
+551
+6% +$12.6K
UI icon
2216
Ubiquiti
UI
$31.8B
$205K ﹤0.01%
259
-13
-5% -$8.83K
HBT icon
2217
HBT Financial
HBT
$1.33B
$205K ﹤0.01%
7,656
LXEO icon
2218
Lexeo Therapeutics
LXEO
$335M
$204K ﹤0.01%
35,584
-137
-0.4% -$971
AVAH icon
2219
Aveanna Healthcare
AVAH
$2.12B
$204K ﹤0.01%
31,691
-7,441
-19% -$57.5K
HTLD icon
2220
Heartland Express
HTLD
$995M
$203K ﹤0.01%
19,516
-2,407
-11% -$25.4K
AMC icon
2221
AMC Entertainment Holdings
AMC
$2.45B
$203K ﹤0.01%
206,754
-81,617
-28% -$105K
WRLD icon
2222
World Acceptance Corp
WRLD
$880M
$203K ﹤0.01%
1,500
-46
-3% -$6.17K
CYBR
2223
DELISTED
CyberArk
CYBR
$202K ﹤0.01%
4,497
-72
-2% -$31.5K
ADCT icon
2224
ADC Therapeutics
ADCT
$139M
$201K ﹤0.01%
53,690
+4,008
+8% +$15.8K
NPCE icon
2225
Neuropace
NPCE
$469M
$201K ﹤0.01%
15,288

Similar funds

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.